Physician profile

Randall Sterkel

Pediatrics · Town and Country, MO

NPI 1720060718

$275.13

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$18.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Tris Pharma INC $49.07 2019
Pfizer INC. $48.69 2019-2024
Kaleo, INC. $45.30 2019-2020
Vertical Pharmaceuticals, LLC $28.08 2019
Shire North American Group INC $27.40 2019
Ironshore Pharmaceuticals INC. $19.78 2020
Sanofi Pasteur INC. $18.50 2019
Rhodes Pharmaceuticals L.P. $14.60 2019
Glaxosmithkline, LLC. $12.36 2019
Abbvie INC. $11.35 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Randall Sterkel

$275.13

in general payments reported 2019-2025

Years
2019-2024
Top company
Tris Pharma INC

https://glasscript.com/doctor/305249/randall-sterkel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.